Clay Thorp is a seasoned professional in the venture capital and pharmaceutical industries, currently serving as General Partner at Hatteras Venture Partners. Previous roles include Chairman of PhaseBio Pharmaceuticals, General Partner at both BioVista Capital (now Hatteras BioCapital) and Catalysta Partners, and Director of Corporate Development at Novalon Pharmaceutical Corporation. Clay's career began with a co-director position at the Student Coalition for Action in Literacy Education (SCALE). Educational qualifications include a master's degree in Public Policy with a concentration in Business/Government from the Harvard Kennedy School and a BA in Math and Art History from the University of North Carolina at Chapel Hill.

Location

Chapel Hill, United States

Links


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Boston Immune Technologies & Therapeutics

BITT has developed a platform for targeting the tumor necrosis factor receptor 2 (TNFR2) oncogene and the potent population of TNFR2 Tregs in the tumor microenvironment.


Employees

1-10

Links